AlphaCentric Advisors’s Microbot Medical MBOT Stock Holding History

AlphaCentric Advisors’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$488K	Buy	250,000 +50,000	+25%	+$102K	0.41%	87
2026 Q1	$482K	Hold	200,000	–	–	0.48%	65
2025 Q4	$400K	Buy	+200,000	New	+$474K	0.4%	83
2024 Q4	$44.8K	Sell	40,000 -60,000	-60%	-$58.7K	0.04%	193
2024 Q3	$89.4K	Hold	100,000	–	–	0.07%	195
2024 Q2	$102K	Hold	100,000	–	–	0.08%	162
2024 Q1	$123K	Hold	100,000	–	–	0.07%	162
2023 Q4	$164K	Hold	100,000	–	–	0.11%	131
2023 Q3	$139K	Hold	100,000	–	–	0.08%	168
2023 Q2	$272K	Hold	100,000	–	–	0.15%	117
2023 Q1	$208K	Hold	100,000	–	–	0.14%	144
2022 Q4	$301K	Hold	100,000	–	–	0.3%	96
2022 Q3	$478K	Buy	+100,000	New	+$514K	0.49%	58
2021 Q4	$750K	Hold	100,000	–	–	0.22%	46
2021 Q3	$703K	Hold	100,000	–	–	0.18%	53
2021 Q2	$794K	Hold	100,000	–	–	0.22%	37
2021 Q1	$851K	Hold	100,000	–	–	0.29%	29
2020 Q4	$689K	Hold	100,000	–	–	0.29%	20
2020 Q3	$764K	Hold	100,000	–	–	0.37%	20
2020 Q2	$691K	Buy	+100,000	New	+$677K	0.39%	22

Other funds holding MBOT

LCM

Lazari Capital Management Woodland Hills, California $325M AUM 32.83% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

KPWS

Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return

Cornerstone Advisory Hunt Valley, Maryland $1.21B AUM 19.13% 1-Year Est. Return

BFSG LLC Irvine, California $1.13B AUM 29.95% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

API

Asset Planning Inc Cypress, California $154M AUM 25.18% 1-Year Est. Return

Guardian Partners Toronto, Canada $1.11B AUM 38.73% 1-Year Est. Return

AlphaCentric Advisors's MBOT Position: Q2 2026 in Review

AlphaCentric Advisors increased its Microbot Medical (MBOT) stake by 25% in Q2 2026, buying an estimated $102K and bringing the position to 250,000 shares worth $488K. The position accounts for 0.41% of the portfolio, ranked #87.

AlphaCentric Advisors first reported a position in MBOT in Q2 2020 and has held it in 20 quarters since. The position peaked at $851K in Q1 2021. 19 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

AlphaCentric Advisors held 250,000 shares of Microbot Medical worth $488K as of Q2 2026.
AlphaCentric Advisors bought 50,000 Microbot Medical shares in Q2 2026, an estimated $102K.
Microbot Medical made up 0.41% of AlphaCentric Advisors's portfolio in Q2 2026, its #87 holding.
AlphaCentric Advisors first reported a position in Microbot Medical in Q2 2020 and has held it in 20 quarters since.
AlphaCentric Advisors's Microbot Medical position peaked at $851K in Q1 2021.
19 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on AlphaCentric Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.